Lipidor AB (publ) (LIPI)의 가격은 얼마입니까?

Lipidor AB (publ) (LIPI)의 가격은 $0.02243487입니다.

Lipidor AB (publ) (LIPI)의 시가 총액은 무엇입니까?

Lipidor AB (publ) (LIPI)의 시가 총액은 $650.09K입니다.

Lipidor AB (publ) (LIPI) 주당순이익

Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.

연도	EPS	변화
2026 (TTM)	$-0.01	-92.68%
2024	0.00	-92.68%
2023	$-0.04	-70.93%
2022	$-0.14	66.50%
2021	$-0.08	2.38%
2020	$-0.08	9.75%
2019	$-0.07	54.89%
2018	$-0.05	125.96%
2017	$-0.02	-29.97%
2016	$-0.03	0.00%

연도

EPS

변화

2026 (TTM)

$-0.01

-92.68%

2024

0.00

-92.68%

2023

$-0.04

-70.93%

2022

$-0.14

66.50%

2021

$-0.08

2.38%

2020

$-0.08

9.75%

2019

$-0.07

54.89%

2018

$-0.05

125.96%

2017

$-0.02

-29.97%

2016

$-0.03

0.00%

회사	EPS	EPS 차이	국가
Eli Lilly and Company LLY.US	$29.85	-328,121.98%	US
Johnson & Johnson JNJ.US	$8.65	-95,154.95%	US
AbbVie Inc. ABBV.US	$3.55	-39,110.99%	US
Roche Holding AG RO.SW	$20.39	-224,154.95%	CH
Merck & Co., Inc. MRK.US	$1.26	-13,946.15%	US

회사

EPS

EPS 차이

국가